GlassScriptPhysician profile
Daniel W Ziegler
NPI 1356368948
$1,778.29
in general payments reported to CMS, 2019-2025
23 companies · $493 in 2025
The $493 reported for 2025 was more than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $423 · 2020: $25.84 · 2021: $49.21 · 2023: $338 · 2024: $450 · 2025: $493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,257 · Travel and Lodging: $23.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,256.51 |
| Travel and Lodging | $23.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $201.39 | 2024 | Endurant Iis |
| Kls-Martin L.P. | $195.84 | 2021-2025 | |
| Integra Lifesciences Corporation | $154.58 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Davol INC. | $130.35 | 2023-2025 | Phasix Mesh, Arista |
| Smith+Nephew, INC. | $123.39 | 2023-2024 | Stravix, Grafix Pl |
| Kerecis Limited | $108.36 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Cook Medical LLC | $103.98 | 2019 | |
| Tetraphase Pharmaceuticals, INC. | $75.24 | 2019 | |
| Avita Medical Americas, LLC | $73.73 | 2024-2025 | Recell, Cohealyx, Permeaderm |
| Janssen Pharmaceuticals, INC | $69.86 | 2019-2020 | |
| Mimedx Group, INC. | $67.84 | 2024-2025 | |
| Tela Bio, INC. | $67.37 | 2019 | |
| Biotissue Holdings INC. | $63.21 | 2023 | |
| Aroa Biosurgery Incorporated | $61.52 | 2025 | |
| Intuitive Surgical, INC. | $59.43 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Access Pro Medical, LLC | $52.00 | 2023 | Matriderm |
| Musculoskeletal Transplant Foundation INC. | $47.99 | 2023-2025 | |
| Acell, INC. | $30.19 | 2019 | |
| Acera Surgical, INC. | $27.38 | 2025 | Restrata Wound Matrix |
| Axogen | $21.68 | 2025 | |
| Ethicon US, LLC | $15.19 | 2019 | |
| Kci USA, INC. | $14.94 | 2019 | |
| Covidien LP | $12.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Ziegler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.